← Back to patent-cliff list
CAS 1620056-47-4
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Chain position details for this CAS are not yet recorded.
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications |
|---|---|---|---|---|---|
| Unibest Taizhou GMP-like Site | Carbamic acid, N-[(1S)-1-(3,6-dibromo-2-pyridinyl)-2-(3,5-difluorophenyl)ethyl]-, 1,1-dimethylethyl ester Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
Listed key intermediates
| Product / CAS | Purity / impurities | Capacity | Qualifications | Packing / cold chain | MOQ / price band | Action |
|---|---|---|---|---|---|---|
Lenacapavir INT-1｜N-Boc 手性胺酯 1620056-47-4 | ≥99.0% | 1,200 kg/年 | US DMF | 5 kg / 25 kg 桶（铝箔袋内衬） | 1 kg · US$ 2,600-3,800 / kg |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.